Amedeo Smart

Free Medical Literature Service



HIV Infection

  Free Subscription

Articles published in
J Med Virol
    August 2021
  1. HASAN MM, Mohanan P, Emmanuella N, Costa ACDS, et al
    Challenges of HIV amidst COVID-19 in Africa: Can we conquer them?
    J Med Virol. 2021 Aug 17. doi: 10.1002/jmv.27276.
    >> Share

  2. COUSIN E, Belicard F, Michel L, Pronier C, et al
    Severe cytomegalovirus disease with encephalitis after CAR-T cell therapy: a rare but potentially fatal complication.
    J Med Virol. 2021 Aug 9. doi: 10.1002/jmv.27257.
    >> Share

    July 2021
  3. PEREIRA-VAZ J, Crespo P, Mocho L, Martinho P, et al
    Identification of a new 2-amino acid insertion in the integrase coding region of HIV-1 subtype G isolates.
    J Med Virol. 2021 Jul 14. doi: 10.1002/jmv.27205.
    >> Share

    June 2021
  4. ULLAH I, Hassan W, Tahir MJ, Ahmed A, et al
    Antiretrovirals shortage in Kenya amid COVID-19.
    J Med Virol. 2021 Jun 18. doi: 10.1002/jmv.27134.
    >> Share

    May 2021
  5. TING Y, Liang S, Yang S, Lin Y, et al
    Phylogenetic characteristics of HIV among female cross-border travelers in Yunnan Province between 2003 and 2012.
    J Med Virol. 2021 May 11. doi: 10.1002/jmv.27079.
    >> Share

    April 2021
  6. SANTINELLI L, De Girolamo G, Borrazzo C, Vassalini P, et al
    Alteration of type I interferon response is associated with subclinical atherosclerosis in virologically suppressed HIV-1-infected male patients.
    J Med Virol. 2021 Apr 29. doi: 10.1002/jmv.27028.
    >> Share

  7. PATEL UK, Malik P, Li Y, Habib A, et al
    Stroke and HIV-Associated Neurological Complications: A Retrospective Nationwide Study.
    J Med Virol. 2021 Apr 10. doi: 10.1002/jmv.27010.
    >> Share

  8. BULFONI M, Pravisani R, Dalla E, Cesselli D, et al
    miRNA expression profiles in liver grafts of HCV and HIV/HCV infected recipients, six months after liver transplantation.
    J Med Virol. 2021 Apr 5. doi: 10.1002/jmv.26999.
    >> Share

    March 2021
  9. ARRAIS CRA, Lima K, Barreiros M, Rodrigues JKF, et al
    HIV-1 Subtypes and Drug Resistance in Children During Antiretroviral Therapy in Brazil.
    J Med Virol. 2021 Mar 31. doi: 10.1002/jmv.26988.
    >> Share

  10. WU Y, Yang Y, Wei H, Jia L, et al
    Mortality Predictors among Patients with HIV-Associated Pulmonary Tuberculosis in Northeast China: A Retrospective Cohort Analysis.
    J Med Virol. 2021 Mar 31. doi: 10.1002/jmv.26977.
    >> Share

    February 2021
  11. OLUSOLA BA, Olaleye DO, Odaibo GN
    New Infections and HIV-1 Subtypes Among Febrile Persons and Blood Donors in Oyo State, Nigeria.
    J Med Virol. 2021 Feb 16. doi: 10.1002/jmv.26872.
    >> Share

  12. ROJAS-BOLIVAR D, Intimayta-Escalante C, Cardenas-Jara A, Jandarov R, et al
    COVID-19 case fatality rate and tuberculosis in a metropolitan setting.
    J Med Virol. 2021 Feb 11. doi: 10.1002/jmv.26868.
    >> Share

    January 2021
  13. NASREDDINE R, Florence E, Moutschen M, Yombi JC, et al
    Clinical characteristics and outcomes of COVID-19 in people living with HIV in Belgium: A multicenter, retrospective cohort.
    J Med Virol. 2021 Jan 28. doi: 10.1002/jmv.26828.
    >> Share

  14. O'ROURKE S, O'Flaherty N, Coyne D, Lynam A, et al
    Seroprevalence of human herpesvirus 8 in Ireland among blood donors, men who have sex with men and heterosexual Genitourinary Medicine and Infectious Diseases clinic attendees.
    J Med Virol. 2021 Jan 21. doi: 10.1002/jmv.26813.
    >> Share

  15. HUANG XH, Yu G, Zheng C, Zhou PP, et al
    Genomic characterization of a new CRF01_AE/CRF07_BC case from a MSM patient in Guangdong, China.
    J Med Virol. 2021 Jan 15. doi: 10.1002/jmv.26799.
    >> Share

    December 2020
  16. DUBEY RC, Alam NB, Gaur R
    miR-150-mediated increase in glucose uptake in HIV-infected cells.
    J Med Virol. 2020 Dec 24. doi: 10.1002/jmv.26755.
    >> Share

  17. SARKAR S, Khanna P, Singh AK
    Impact of COVID-19 in patients with concurrent co-infections: a systematic review and meta-analyses.
    J Med Virol. 2020 Dec 17. doi: 10.1002/jmv.26740.
    >> Share

  18. ANNAMALAY AA, Abbott S, Khoo SK, Hibbert J, et al
    The Impact of Cytokine Levels in Young South African Children with and without HIV-associated Acute Lower Respiratory Infections.
    J Med Virol. 2020 Dec 14. doi: 10.1002/jmv.26730.
    >> Share

  19. LATHOUWERS E, Weinsteiger S, Baugh B, Ghys A, et al
    Week 96 resistance analyses of the once-daily, Single-tablet Regimen (STR) Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) in adults living with HIV-1 from the phase 3 randomized AMBER and EMERALD trials.
    J Med Virol. 2020 Dec 10. doi: 10.1002/jmv.26721.
    >> Share

  20. WAN T, Liu X, Su Y, Zou J, et al
    Biological Differentiation of Traditional Chinese Medicine from Excessive to Deficient Syndromes in AIDS: Comparative MicroRNA Microarray Profiling and Syndrome-Specific Biomarker Identification.
    J Med Virol. 2020 Dec 2. doi: 10.1002/jmv.26704.
    >> Share

    November 2020
  21. SWAMINATHAN N, Moussa P, Mody N, Bryan Lo K, et al
    COVID-19 in HIV infected patients: A Case series and Literature Review.
    J Med Virol. 2020 Nov 17. doi: 10.1002/jmv.26671.
    >> Share

  22. ZENG J, Zhang X, Jia L, Wu Y, et al
    Pretreatment Lymphocyte-to-Monocyte Ratios Predict AIDS-related Diffuse Large B-Cell Lymphoma Overall Survival.
    J Med Virol. 2020 Nov 6. doi: 10.1002/jmv.26655.
    >> Share

    October 2020
  23. TEKIN D, Gokengin D, Onay H, Erensoy S, et al
    Investigation of Drug Resistance Against Protease, Reverse Transcriptase and Integrase Inhibitors by Next Generation Sequencing in HIV Positive Patients.
    J Med Virol. 2020 Oct 7. doi: 10.1002/jmv.26582.
    >> Share

  24. CAKIR B
    The outcome of COVID-19 in patients with hematological malignancy.
    J Med Virol. 2020 Oct 2. doi: 10.1002/jmv.26576.
    >> Share

    September 2020
  25. LY HI, Kelly M, Fall MVM, Fall-Malick FZ, et al
    Prevalence of therapeutic failure and evolution of biological factors amongst people living with HIV enrolled in anti-retroviral therapy at the Ambulatory Treatment Center in Nouakchott, Mauritania.
    J Med Virol. 2020 Sep 28. doi: 10.1002/jmv.26562.
    >> Share

  26. MONDI A, Cimini E, Colavita F, Cicalini S, et al
    COVID-19 in people living with HIV: clinical implications of dynamics of immune response to SARS-CoV-2.
    J Med Virol. 2020 Sep 25. doi: 10.1002/jmv.26556.
    >> Share

  27. NAGARAKANTI SR, Okoh AK, Grinberg S, Bishburg E, et al
    Clinical outcomes of patients with COVID-19 and HIV coinfection.
    J Med Virol. 2020 Sep 19. doi: 10.1002/jmv.26533.
    >> Share

  28. DA SILVA DM, Goncales JP, Silva Junior JVJ, Lopes TRR, et al
    Evaluation of IL-2, IL-4, IL-6, IL-10, TNF-alpha and IFN-gamma cytokines in HIV/HHV-8 coinfection.
    J Med Virol. 2020 Sep 14. doi: 10.1002/jmv.26516.
    >> Share

    August 2020
    Pearls and Pitfalls: two contrasting HIV diagnoses in the COVID-19 era and the case for screening.
    J Med Virol. 2020 Aug 13. doi: 10.1002/jmv.26428.
    >> Share

  30. LU J, Jia J, Zhang J, Liu X, et al
    HIV p17 enhances T cell proliferation by suppressing autophagy through the p17-OLA1-GSK3beta axis under nutrient starvation.
    J Med Virol. 2020 Aug 13. doi: 10.1002/jmv.26423.
    >> Share

  31. PATEL RH, Acharya A, Mohan M, Byrareddy SN, et al
    COVID-19 and AIDS: outcomes from the co-existence of two global pandemics and the importance of chronic antiretroviral therapy.
    J Med Virol. 2020 Aug 11. doi: 10.1002/jmv.26416.
    >> Share

  32. MALTEZOU HC, Vorou R, Papadima K, Kossyvakis A, et al
    Transmission dynamics of SARS-CoV-2 within families with children in Greece: a study of 23 clusters.
    J Med Virol. 2020 Aug 7. doi: 10.1002/jmv.26394.
    >> Share

  33. PATRA R, Chandra Das N, Mukherjee S
    Targeting human TLRs to combat COVID-19: A solution?
    J Med Virol. 2020 Aug 4. doi: 10.1002/jmv.26387.
    >> Share

    July 2020
  34. ZHAO T, Xuan K, Uy JP, Sun C, et al
    In the shadow of COVID-19: HIV-infected individuals need more attention.
    J Med Virol. 2020 Jul 31. doi: 10.1002/jmv.26378.
    >> Share

  35. SUWANWONGSE K, Shabarek N
    Variation in mortality of HIV/SARS-CoV-2 co-infected patients in the Bronx, New York City.
    J Med Virol. 2020 Jul 29. doi: 10.1002/jmv.26370.
    >> Share

  36. BARRERA-LOPEZ P, Perez-Riveros ED, Moreno-Montoya J, Ballesteros SM, et al
    Co-infection of other respiratory pathogens and HIV in COVID-19 patients: is there a pattern?
    J Med Virol. 2020 Jul 24. doi: 10.1002/jmv.26331.
    >> Share

  37. MAGGIOLO F, Zoboli F, Arosio M, Valenti D, et al
    SARS-CoV-2 infection in persons living with HIV: a single center prospective cohort.
    J Med Virol. 2020 Jul 24. doi: 10.1002/jmv.26352.
    >> Share

  38. RAMASWAMY M, Bruden D, Nolen LD, Mosites E, et al
    Hepatitis A vaccine immunogenicity 25 years after vaccination in Alaska.
    J Med Virol. 2020 Jul 22. doi: 10.1002/jmv.26327.
    >> Share

  39. KANWUGU ON, Adadi P
    HIV/SARS-CoV-2 coinfection: a global perspective.
    J Med Virol. 2020 Jul 21. doi: 10.1002/jmv.26321.
    >> Share

  40. LIU L, Deng R, Lan Y, Li L, et al
    Multicenter evaluation of Xpert(R) HIV-1 Viral Load assay for HIV Quantification in China.
    J Med Virol. 2020 Jul 11. doi: 10.1002/jmv.26295.
    >> Share

  41. DAI L, Jung BG, Chen J, Samten B, et al
    The potential impacts of early secreted antigenic target of 6 kDa (ESAT-6) of Mycobacterium tuberculosis on KSHV-infected cells.
    J Med Virol. 2020 Jul 10. doi: 10.1002/jmv.26291.
    >> Share

  42. ZHANG K, Wei B, Tang Z, Wei Y, et al
    Acute HIV infection in a large teaching hospital in western China: clinical, virological and molecular epidemiological characteristics.
    J Med Virol. 2020 Jul 9. doi: 10.1002/jmv.26282.
    >> Share

  43. MASUKUME G, Mapanga W, Grinberg S, van Zyl DS, et al
    COVID-19 and HIV co-infection an emerging consensus.
    J Med Virol. 2020 Jul 7. doi: 10.1002/jmv.26270.
    >> Share

  44. MARIMUTHU J, Kumar BS, Aravind Gandhi P
    HIV and SARS CoV-2 co-infection: A retrospective, record based, case series from South India.
    J Med Virol. 2020 Jul 7. doi: 10.1002/jmv.26271.
    >> Share

  45. PRZYDZIAL P, Tchomobe G, Amin K, Christian E, et al
    When COVID-19 Crosses Paths with AIDS in the Homeless.
    J Med Virol. 2020 Jul 3. doi: 10.1002/jmv.26255.
    >> Share

  46. BALENA F, Bavaro DF, Volpe A, Lagioia A, et al
    Influence of HIV-1 V2 sequence variability on bacterial translocation in antiretroviral naive HIV-1 infected patients.
    J Med Virol. 2020 Jul 1. doi: 10.1002/jmv.26246.
    >> Share

    June 2020
  47. RUAN L, Zhang Y, Luo Y, Yu X, et al
    Clinical features and outcomes of four HIV patients with COVID-19 in Wuhan, China.
    J Med Virol. 2020 Jun 25. doi: 10.1002/jmv.26223.
    >> Share

  48. KO K, Nagashima S, Yamamoto C, Takahashi K, et al
    18 Years Follow-up Cohort Study on Hepatitis B and C Virus Infections Related Long Term Prognosis among Hemodialysis Patients in Hiroshima.
    J Med Virol. 2020 Jun 24. doi: 10.1002/jmv.26215.
    >> Share

  49. TOOMBS JM, Van den Abbeele K, Democratis J, Merricks R, et al
    COVID-19 in 3 people living with HIV in the United Kingdom.
    J Med Virol. 2020 Jun 15. doi: 10.1002/jmv.26178.
    >> Share

  50. PATEL RH
    Clinical Outcomes and Prognosis of Patients with HIV and SARS-CoV-2 Co-infection.
    J Med Virol. 2020 Jun 15. doi: 10.1002/jmv.26177.
    >> Share

  51. LI W, Ma Q, Wang X, Tang M, et al
    Letter to the Editor: The characteristics of two patients co-infected with SARS-CoV-2 and HIV in Wuhan, China.
    J Med Virol. 2020 Jun 10. doi: 10.1002/jmv.26155.
    >> Share

  52. SEBASTIAO CS, Neto Z, Jandondo D, Mirandela M, et al
    HIV, hepatitis B virus, hepatitis C virus, and syphilis among pregnant women attending antenatal care in Luanda, Angola: seroprevalence and risk factors.
    J Med Virol. 2020 Jun 9. doi: 10.1002/jmv.26148.
    >> Share

  53. ADADI P, Kanwugu ON
    Living with HIV in the time of COVID-19: a glimpse of hope.
    J Med Virol. 2020 Jun 4. doi: 10.1002/jmv.26118.
    >> Share

  54. TAGNOUOKAM-NGOUPO PA, Toby R, Ebede MOB, Kenmoe S, et al
    Detection of Herpesviruses and Enteroviruses in Patients with Suspected Infectious Meningoencephalitis in Three Referral Hospitals in Yaounde, Cameroon.
    J Med Virol. 2020 Jun 3. doi: 10.1002/jmv.26109.
    >> Share

  55. NAKAMOTO T, Kutsuna S, Yanagawa Y, Kanda K, et al
    A case of SARS-CoV-2 infection in an untreated HIV patient in Tokyo, Japan.
    J Med Virol. 2020 Jun 3. doi: 10.1002/jmv.26102.
    >> Share

    May 2020
  56. MOHAMADI M, Azarbayjani K, Mozhgani SH, Bamdad T, et al
    Hepatitis C virus alternative reading frame protein (ARFP): production, features and pathogenesis.
    J Med Virol. 2020 May 29. doi: 10.1002/jmv.26091.
    >> Share

  57. SUWANWONGSE K, Shabarek N
    Clinical features and outcome of HIV/SARS-CoV-2 co-infected patients in the Bronx, New York City.
    J Med Virol. 2020 May 28. doi: 10.1002/jmv.26077.
    >> Share

  58. PRATES G, Malta FM, Toledo F, Fonseca LAM, et al
    AIDS incidence and survival in a hospital-based cohort of HIV-positive patients from Sao Paulo, Brazil: the role of IFN-lambda 4 polymorphisms.
    J Med Virol. 2020 May 25. doi: 10.1002/jmv.26054.
    >> Share

  59. IORDANOU S, Koukios D, Matsentidou CT, Markoulaki D, et al
    Severe SARS-CoV-2 pneumonia in a 58-year-old patient with HIV: a clinical case report from the Republic of Cyprus.
    J Med Virol. 2020 May 25. doi: 10.1002/jmv.26053.
    >> Share

  60. PATEL RH, Pella PM
    COVID-19 in a patient with HIV infection.
    J Med Virol. 2020 May 22. doi: 10.1002/jmv.26049.
    >> Share

  61. BALUKU JB, Mwebaza S, Ingabire G, Nsereko C, et al
    HIV and SARS-CoV-2 co-infection: A case report from Uganda.
    J Med Virol. 2020 May 21. doi: 10.1002/jmv.26044.
    >> Share

  62. DAI L, Barrett L, Plaisance-Bonstaff K, Post SR, et al
    Porphyromonas gingivalis co-infects with KSHV in oral cavities of HIV+ patients and induces viral lytic reactivation.
    J Med Virol. 2020 May 21. doi: 10.1002/jmv.26028.
    >> Share

  63. BENKOVIC S, Kim M, Sin E
    4 Cases: HIV and SARS-CoV-2 Co-infection in patients from Long Island, New York.
    J Med Virol. 2020 May 19. doi: 10.1002/jmv.26029.
    >> Share

  64. WU Q, Chen T, Zhang H
    Recovery from COVID-19 in two patients with coexisted HIV infection.
    J Med Virol. 2020 May 13. doi: 10.1002/jmv.26006.
    >> Share

  65. MUSARRAT F, Chouljenko V, Dahal A, Nabi R, et al
    The anti-HIV Drug Nelfinavir Mesylate (Viracept) is a Potent Inhibitor of Cell Fusion Caused by the SARS-CoV-2 Spike (S) Glycoprotein Warranting further Evaluation as an Antiviral against COVID-19 infections.
    J Med Virol. 2020 May 6. doi: 10.1002/jmv.25985.
    >> Share

  66. AMSTUTZ A, Nsakala BL, Cheleboi M, Lejone TI, et al
    Low rates of active hepatitis B and C infections among adults and children living with HIV and taking antiretroviral therapy: a multicenter screening study in Lesotho.
    J Med Virol. 2020 May 5. doi: 10.1002/jmv.25970.
    >> Share

    April 2020
  67. ALTUNTAS AYDIN O, Kumbasar Karaosmanoglu H, Kart Yasar K
    HIV/SARS-CoV-2 co-infected patients in Istanbul, Turkey.
    J Med Virol. 2020 Apr 29. doi: 10.1002/jmv.25955.
    >> Share

  68. DA SILVA BEB, Santos VS, Reis Santos IE, Araujo ED, et al
    Prevalence and genotype distribution of human papillomavirus in women living with HIV/AIDS in an area of Northeast Brazil.
    J Med Virol. 2020 Apr 24. doi: 10.1002/jmv.25935.
    >> Share

  69. PASSOS DF, Bremm JM, da Silveira LL, Janstch MH, et al
    CD4/CD8 ratio, comorbidities and aging in treated HIV infected individuals on viral suppression.
    J Med Virol. 2020 Apr 21. doi: 10.1002/jmv.25911.
    >> Share

  70. NISAR N, Aamir UB, Badar N, Mahmood MR, et al
    Epidemiology of Influenza among patients with influenza-like illness and severe acute respiratory illness in Pakistan: a 10-year surveillance study 2008-17.
    J Med Virol. 2020 Apr 21. doi: 10.1002/jmv.25913.
    >> Share

  71. CALZA L, Tamburello M, Borderi M, Colangeli V, et al
    Prevalence of Transmitted Drug Resistance Mutations Among Newly Diagnosed HIV-1-Infected Patients in a Large Teaching Hospital of the Northern Italy.
    J Med Virol. 2020 Apr 16. doi: 10.1002/jmv.25896.
    >> Share

  72. MASCOLO S, Romanelli A, Carleo MA, Esposito V, et al
    Could HIV infection alter the clinical course of SARS-CoV-2 infection? When less is better.
    J Med Virol. 2020 Apr 15. doi: 10.1002/jmv.25881.
    >> Share

  73. CHEN J, Cheng X, Wang R, Zeng X, et al
    Computed Tomography Imaging of an HIV-infected Patient with Coronavirus Disease 2019 (COVID-19).
    J Med Virol. 2020 Apr 14. doi: 10.1002/jmv.25879.
    >> Share

  74. LELIE N, van Drimmelen H
    Accuracy of quantitative HIV-1 RNA test methods at 1000 copies/mL and potential impact of differences in assay calibration on therapy monitoring of patients.
    J Med Virol. 2020 Apr 14. doi: 10.1002/jmv.25877.
    >> Share

  75. PISATURO M, Onorato L, Russo A, Coppola N, et al
    Prevalence of Occult HBV Infection in Western Countries.
    J Med Virol. 2020 Apr 10. doi: 10.1002/jmv.25867.
    >> Share

  76. LI W, Li X, He Y, Ge Y, et al
    The evolutionary and transmission characteristic of HIV-1 CRF07_BC in Nanjing, Jiangsu.
    J Med Virol. 2020 Apr 10. doi: 10.1002/jmv.25854.
    >> Share

  77. DA COSTA CP, Rodrigues JKF, de Morais VMS, de Andrade CADN, et al
    HIV-1 Subtype Frequency in Northeast Brazil: A Systematic Review and Meta-Analysis.
    J Med Virol. 2020 Apr 8. doi: 10.1002/jmv.25842.
    >> Share

  78. ZHU F, Cao Y, Xu S, Zhou M, et al
    Reply to Comments on 'Co-infection of SARS-CoV-2 and HIV in a patient in Wuhan city, China'.
    J Med Virol. 2020 Apr 8. doi: 10.1002/jmv.25838.
    >> Share

  79. ZHANG B, Ma Q, Zhao B, Wang L, et al
    Performance evaluation of Elecsys(R) HIV Duo on cobas e 801 using clinical samples in China.
    J Med Virol. 2020 Apr 8. doi: 10.1002/jmv.25845.
    >> Share

  80. CURE E, Cumhur Cure M
    Comment on "Organ-protective Effect of Angiotensin-converting Enzyme 2 and its Effect on the Prognosis of COVID-19".
    J Med Virol. 2020 Apr 8. doi: 10.1002/jmv.25848.
    >> Share

  81. NIXON DF
    Comments on 'Co-infection of SARS-CoV-2 and HIV in a patient in Wuhan city, China'.
    J Med Virol. 2020 Apr 3. doi: 10.1002/jmv.25821.
    >> Share

    March 2020
  82. JAMSHIDI S, Bokharaei-Salim F, Esghaei M, Bastani MN, et al
    Occult HCV and Occult HBV Co-infection in Iranian Human Immunodeficiency Virus-Infected Individuals.
    J Med Virol. 2020 Mar 31. doi: 10.1002/jmv.25808.
    >> Share

    Concerns regarding calculation of fatality rate of Chinese samples in COVID-19 meta-analysis.
    J Med Virol. 2020 Mar 30. doi: 10.1002/jmv.25799.
    >> Share

  84. JOOB B, Wiwanitkit V
    SARS-CoV-2 and HIV.
    J Med Virol. 2020 Mar 27. doi: 10.1002/jmv.25782.
    >> Share

  85. ZHU F, Cao Y, Xu S, Zhou M, et al
    Co-infection of SARS-CoV-2 and HIV in a patient in Wuhan city, China.
    J Med Virol. 2020 Mar 11. doi: 10.1002/jmv.25732.
    >> Share

  86. GUAN X, Han M, Li Z, Wang L, et al
    HIV-1 Genetic Diversity and Transmitted Drug Resistance among Newly Diagnosed HIV-1 Individuals in Jiangmen, China.
    J Med Virol. 2020 Mar 1. doi: 10.1002/jmv.25741.
    >> Share

  87. OH JJ, Carter JJ, Nemeno JGE, Dix RD, et al
    Parthanatos-associated proteins are stimulated intraocularly during development of experimental murine cytomegalovirus retinitis in mice with retrovirus-induced immunosuppression.
    J Med Virol. 2020;92:394-398.
    >> Share

    February 2020
  88. LI X, Zai J, Zhao Q, Nie Q, et al
    Evolutionary history, potential intermediate animal host, and cross-species analyses of SARS-CoV-2.
    J Med Virol. 2020 Feb 27. doi: 10.1002/jmv.25731.
    >> Share

  89. WAHID B
    Worst outbreaks of leishmaniasis and HIV AIDS in Pakistan: An update from 2019.
    J Med Virol. 2020 Feb 3. doi: 10.1002/jmv.25671.
    >> Share

    January 2020
  90. ZHANG T, Chen X, Liao G, Hu M, et al
    Induction of Cross-neutralizing Antibodies by Sequential Immunization with Heterologous Papillomavirus L1VLPs and its Implications for HPV Prophylactic Vaccines.
    J Med Virol. 2020 Jan 29. doi: 10.1002/jmv.25690.
    >> Share

  91. MOHAMAD ISA II, Abu Bakar S, Ab Rahman AK
    Ethnicity as predictor of immune reconstitution among Malaysian HIV-positive patients treated with highly active antiretroviral therapy (HAART).
    J Med Virol. 2020 Jan 20. doi: 10.1002/jmv.25680.
    >> Share

  92. MANN JK, Rajkoomar E, Jin SW, Mkhize Q, et al
    Consequences of HLA-associated mutations in HIV-1 subtype C Nef on HLA-I down-regulation ability.
    J Med Virol. 2020 Jan 16. doi: 10.1002/jmv.25676.
    >> Share

    December 2019
  93. ONORIODE DIGBAN T, Chucks Iweriebor B, Chikwelu Obi L, Nwodo U, et al
    Analyses of HIV-1 Integrase gene Sequences among treatment naive patients in the Eastern Cape, South Africa.
    J Med Virol. 2019 Dec 30. doi: 10.1002/jmv.25661.
    >> Share

  94. DONYAVI T, Bokharaei-Salim F, Nahand JS, Garshasbi S, et al
    Evaluation of CCR5-Delta32 Mutation among Individuals with High Risk Behaviours, Neonates Born to HIV-1 Infected Mothers, HIV-1 Infected Individuals, and Healthy People in an Iranian Population.
    J Med Virol. 2019 Dec 19. doi: 10.1002/jmv.25658.
    >> Share

  95. LOUREIRO DOS REIS MM, Freitas Queiroz MA, Maciel da Silva BC, da Silva Duarte AJ, et al
    IL6 and FAS/FASL gene polymorphisms may be associated with disease progression in HIV-1-positive ethnically mixed patients.
    J Med Virol. 2019 Dec 11. doi: 10.1002/jmv.25651.
    >> Share

    November 2019
  96. WANG L, Santella AJ, Wei X, Zhuang G, et al
    Prevalence and protective factors of HIV and syphilis infection among men who have sex with men in Northwest China.
    J Med Virol. 2019 Nov 7. doi: 10.1002/jmv.25622.
    >> Share

    October 2019
  97. REN L, Wang B, Miao Z, Liu P, et al
    A Correlation Analysis of HHV Infection and Its Predictive Factors in An HIV-seropositive Population in Yunnan, China.
    J Med Virol. 2019 Oct 17. doi: 10.1002/jmv.25609.
    >> Share

    September 2019
  98. ZHENG B, Zhang J, Zheng T, Wang H, et al
    ATP1B3 Cooperates with BST-2 to Promote Hepatitis B Virus Restriction.
    J Med Virol. 2019 Sep 26. doi: 10.1002/jmv.25599.
    >> Share

  99. TANNOCK GA, Kim H, Xue L
    Why are vaccines against many human viral diseases still unavailable; an historic perspective?
    J Med Virol. 2019 Sep 10. doi: 10.1002/jmv.25593.
    >> Share

  100. SYED F, Yu Q
    Cofilin, an intracellular marker for HIV-associated CD4 T-cell motility dysregulation, shed light on the mechanisms of incomplete immune reconstitution in the patients with HIV.
    J Med Virol. 2019 Sep 9. doi: 10.1002/jmv.25577.
    >> Share

    August 2019
  101. MARGOT NA, Ram RR, White KL, Abram ME, et al
    Antiviral Activity of HIV-1 Integrase Strand Transfer Inhibitors against Mutants with Integrase Resistance-Associated Mutations and their Frequency in Treatment-Naive Individuals.
    J Med Virol. 2019 Aug 7. doi: 10.1002/jmv.25564.
    >> Share

    July 2019
  102. WAHID B
    Hepatotoxicity and virological breakthrough of HCV following treatment with sofosbuvir, daclatasvir, and ribavirin in patient previously treated for Tuberculosis.
    J Med Virol. 2019 Jul 26. doi: 10.1002/jmv.25557.
    >> Share

  103. MOZHGANI SH, Ghobadi MZ, Rad MB, Farzanehpour M, et al
    Reconnaissance of candidate genes involved in human immunodeficiency virus (HIV) pathogenesis and targeted by antiretroviral therapy.
    J Med Virol. 2019 Jul 18. doi: 10.1002/jmv.25549.
    >> Share

  104. FENG S, Wang Z, Zhao Y, Ji G, et al
    Long non-coding RNA GAS5 does not regulate HBV replication.
    J Med Virol. 2019 Jul 13. doi: 10.1002/jmv.25547.
    >> Share

  105. MODIYINJI AF, Atsama MA, Monamele CG, Nola M, et al
    Seroprevalence of Hepatitis E virus antibodies in different human populations of Cameroon.
    J Med Virol. 2019 Jul 12. doi: 10.1002/jmv.25545.
    >> Share

  106. WU J, Liu Q, Xie H, Chen R, et al
    Screening and evaluation of potential inhibitors against vaccinia virus from 767 approved drugs.
    J Med Virol. 2019 Jul 11. doi: 10.1002/jmv.25544.
    >> Share

  107. GIANOTTI N, Muccini C, Galli L, Poli A, et al
    Homeostatic Model Assessment for Insulin Resistance Index Trajectories in HIV-infected Patients Treated with Different First-line Antiretroviral Regimens.
    J Med Virol. 2019 Jul 9. doi: 10.1002/jmv.25541.
    >> Share

    June 2019
  108. CICCOZZI M, Lai A, Zehender G, Borsetti A, et al
    The phylogenetic approach for viral infectious disease evolution and epidemiology: an updating review.
    J Med Virol. 2019 Jun 27. doi: 10.1002/jmv.25526.
    >> Share

  109. LUO G, Sun X, Li M, Liu T, et al
    Cervical human papillomavirus among women in Guangdong, China 2008-2017: Implication for screening and vaccination.
    J Med Virol. 2019 Jun 17. doi: 10.1002/jmv.25520.
    >> Share

  110. GIACOMELLI A, Fabbiani M, De Benedetto I, Nozza S, et al
    Impact of genotypic susceptibility score on cART outcomes during primary HIV infection.
    J Med Virol. 2019 Jun 14. doi: 10.1002/jmv.25517.
    >> Share

  111. WANG SM, Huang KJ, Wang CT
    Severe acute respiratory syndrome coronavirus spike protein counteracts BST2-mediated restriction of virus-like particle release.
    J Med Virol. 2019 Jun 14. doi: 10.1002/jmv.25518.
    >> Share

    May 2019
  112. LI J, Lai H, Chen S, Kickler T, et al
    Cocaine use modifies the association between antiretroviral therapy and endothelial dysfunction among adults with HIV infection.
    J Med Virol. 2019 May 29. doi: 10.1002/jmv.25507.
    >> Share

  113. THEPBUNDIT V, Ngo-Giang-Huong N, Salvadori N, Laolue A, et al
    Feasibility of using dried blood spots for HIV viral load testing among HIV-infected individuals in Thailand using QIAGEN QIAsymphony-artus HIV-1 platform.
    J Med Virol. 2019 May 16. doi: 10.1002/jmv.25506.
    >> Share

    April 2019
  114. JEAN MJ, Zhou D, Fiches G, Kong W, et al
    Curaxin CBL0137 has the potential to reverse HIV-1 latency.
    J Med Virol. 2019 Apr 16. doi: 10.1002/jmv.25487.
    >> Share

    March 2019
  115. ALIDJINOU EK, Deldalle J, Robineau O, Hallaert C, et al
    Routine drug resistance testing in proviral HIV-1 DNA: prevalence of stop codons and hypermutation, and associated factors.
    J Med Virol. 2019 Mar 30. doi: 10.1002/jmv.25474.
    >> Share

  116. MAYAPHI SH, Martin DJ, Quinn TC, Stoltz AC, et al
    Field Performance of the INSTI HIV-1/-2 Antibody Test in Two South African Antenatal Clinics.
    J Med Virol. 2019 Mar 6. doi: 10.1002/jmv.25447.
    >> Share

  117. WEI X, Zhang Y, Santella AJ, Wang L, et al
    Effect of early highly active antiretroviral therapy on viral suppression among newly diagnosed men who have sex with men living with HIV in Xi'an, China.
    J Med Virol. 2019 Mar 6. doi: 10.1002/jmv.25449.
    >> Share

    January 2019
  118. GOPALAN BP, D'Souza RR, Rajnala N, Arumugam K, et al
    Viral evolution in the cell-associated HIV-1 DNA during early ART can lead to drug-resistance and virological failure in children.
    J Med Virol. 2019 Jan 29. doi: 10.1002/jmv.25413.
    >> Share

    December 2018
  119. BAVARO DF, Saracino A, Fiordelisi D, Bruno G, et al
    Influence of HLA-B18 on liver fibrosis progression in a cohort of HIV/HCV co-infected individuals.
    J Med Virol. 2018 Dec 22. doi: 10.1002/jmv.25385.
    >> Share

  120. LIU Y, Margot N, Kitrinos KM, Callebaut C, et al
    Development of an HIV-1 Integrase Genotyping Assay for HIV-1 Subtype AE.
    J Med Virol. 2018 Dec 13. doi: 10.1002/jmv.25376.
    >> Share

  121. SINGH L, Bell TG, Yousif M, Kramvis A, et al
    Response of hepatitis B virus to anti-retroviral treatment containing lamivudine in HBsAg-positive and HBsAg-negative HIV-positive South African adults.
    J Med Virol. 2018 Dec 4. doi: 10.1002/jmv.25375.
    >> Share

    November 2018
  122. MALAGNINO V, Bottero J, Miailhes P, Lascoux-Combe C, et al
    Hepatitis B virus genotype G and liver fibrosis progression in chronic hepatitis B and human immunodeficiency virus coinfection.
    J Med Virol. 2018 Nov 15. doi: 10.1002/jmv.25360.
    >> Share

    September 2018
  123. ROLDAN EQ, Properzi M, Amadasi S, Raffetti E, et al
    Prognostic role of inflammatory biomarkers in HIV-infected patients with a first diagnosis of Hepatocellular carcinoma (HCC): a single-centre study.
    J Med Virol. 2018 Sep 14. doi: 10.1002/jmv.25317.
    >> Share

  124. NADAN S, Taylor MB, Groome MJ, Cohen C, et al
    Epidemiology of human astroviruses among children younger than 5 years: Prospective hospital-based sentinel surveillance in South Africa, 2009-2014.
    J Med Virol. 2018 Sep 7. doi: 10.1002/jmv.25308.
    >> Share

  125. GUOPING D, Xiaoshan L, Musa TH, Yu J, et al
    The Nationwide Distribution and Trends of Hepatitis C Virus Genotypes in Mainland China.
    J Med Virol. 2018 Sep 7. doi: 10.1002/jmv.25311.
    >> Share

    August 2018
  126. GILANI US, Memoona, Rasheed A, Shahid M, et al
    The implication of CRISPR/Cas9 genome editing technology in combating human oncoviruses.
    J Med Virol. 2018 Aug 22. doi: 10.1002/jmv.25292.
    >> Share

  127. JORDIER F, Deligny ML, Barre R, Robert C, et al
    Human pegivirus (HPgV) isolates characterized by deep sequencing from HCV- and HIV-RNA positive blood donations, France.
    J Med Virol. 2018 Aug 22. doi: 10.1002/jmv.25290.
    >> Share

  128. KAHYESH-ESFANDIARY R, Sadigh ZA, Esghaei M, Bastani MN, et al
    Detection of HCV Genome in Peripheral Blood Mononuclear Cells of Iranian Seropositive and HCV RNA negative in Plasma of Patients with Beta-thalassemia Major: Occult HCV Infection.
    J Med Virol. 2018 Aug 9. doi: 10.1002/jmv.25279.
    >> Share

  129. FLORES GL, Cruz HM, Miguel JC, Potsch DV, et al
    Assessing Hepatitis B immunity using dried blood spot samples from HIV(+) individuals.
    J Med Virol. 2018 Aug 7. doi: 10.1002/jmv.25275.
    >> Share

    July 2018
  130. JOGEDA EL, Avi R, Pauskar M, Kallas E, et al
    Association of IFNlambda4 rs12979860 Polymorphism with the Acquisition of HCV and HIV Infections among People Who Inject Drugs.
    J Med Virol. 2018 Jul 10. doi: 10.1002/jmv.25258.
    >> Share

  131. SONG JE, Ahn MY, Kim WJ, Kim SW, et al
    Prevalence of CCR5 tropism among HIV-1-infected patients in South Korea.
    J Med Virol. 2018 Jul 7. doi: 10.1002/jmv.25254.
    >> Share

    June 2018
  132. DEGEFA B, Gebreeyesus T, Gebremedhin Z, Melkamu G, et al
    Prevalence of hepatitis B virus, hepatitis C virus and human immunodeficiency virus among blood donors of Mekelle blood bank, Northern Ethiopia: A three year retrospective study.
    J Med Virol. 2018 Jun 15. doi: 10.1002/jmv.25248.
    >> Share

  133. KARKASHADZE E, Dvali N, Bolokadze N, Sharvadze L, et al
    Epidemiology of HIV drug resistance in HIV patients with virologic failure of first-line therapy in the country of Georgia.
    J Med Virol. 2018 Jun 15. doi: 10.1002/jmv.25245.
    >> Share

    May 2018
  134. SMELOV V, Elfstrom KM, Eklund C, Sokolova O, et al
    Determinants of presence of human papillomaviruses in the anal canal of Russian men.
    J Med Virol. 2018 May 24. doi: 10.1002/jmv.25234.
    >> Share

  135. TAMALET C, Tissot-Dupont H, Motte A, Tourres C, et al
    Emergence of uncommon HIV-1 non-B subtypes and circulating recombinant forms and trends in transmission of antiretroviral drug resistance in patients with primary infection during the 2013-2015 period in Marseille, Southeastern France.
    J Med Virol. 2018 May 24. doi: 10.1002/jmv.25228.
    >> Share

  136. HILDENBRAND C, Wedekind L, Li G, vonRentzell JE, et al
    Clinical evaluation of Roche COBAS((R)) AmpliPrep/COBAS((R)) TaqMan((R)) CMV Test using non-plasma samples.
    J Med Virol. 2018 May 24. doi: 10.1002/jmv.25226.
    >> Share

  137. NICOT F, Jeanne N, Raymond S, Delfour O, et al
    Performance comparison of deep sequencing platforms for detecting HIV-1 variants in the pol gene.
    J Med Virol. 2018 May 11. doi: 10.1002/jmv.25224.
    >> Share

  138. DE DIEU LONGO J, Bouassa RM, Simaleko MM, Kouabosso A, et al
    Usefulness of simultaneous screening for HIV- and HCV- specific antibodies and HBsAg by capillary-based multiplex rapid diagnostic test to strengthen linkage-to-care in sub-Saharan patients attending sexually transmitted infections clinic.
    J Med Virol. 2018 May 2. doi: 10.1002/jmv.25209.
    >> Share

    April 2018
  139. KUAI Q, Lu X, Qiao Z, Wang R, et al
    Histone deacetylase inhibitor chidamide promotes reactivation of latent HIV by introducing histone acetylation.
    J Med Virol. 2018 Apr 28. doi: 10.1002/jmv.25207.
    >> Share

  140. PIRAYESHFARD L, Sharifi Z, Amini-Kafiabad S, Sadaghiani NH, et al
    Phylogenetic analysis of HTLV-1 in Iranian blood donors, HIV-1 positive patients and patients with beta thalassemia.
    J Med Virol. 2018 Apr 16. doi: 10.1002/jmv.25192.
    >> Share

  141. MOSITES E, Gounder P, Snowball M, Morris J, et al
    Hepatitis A vaccine immune response 22 years after vaccination.
    J Med Virol. 2018 Apr 16. doi: 10.1002/jmv.25197.
    >> Share

  142. MOSITES E, Gounder P, Snowball M, Morris J, et al
    Hepatitis A vaccine immune response 22 years after vaccination.
    J Med Virol. 2018 Apr 12. doi: 10.1002/jmv.25089.
    >> Share

    March 2018
  143. SINGH R, Mukherjee A, Singla M, Vajpayee M, et al
    Impact of HIV infection and highly active antiretroviral therapy (HAART) on B cell subpopulations in children.
    J Med Virol. 2018 Mar 25. doi: 10.1002/jmv.25074.
    >> Share

  144. CHEN ZW, Liu L, Chen G, Cheung KW, et al
    Surging HIV-1 CRF07_BC epidemic among recently infected men who have sex with men in Fujian, China.
    J Med Virol. 2018 Mar 25. doi: 10.1002/jmv.25072.
    >> Share

  145. DENG H, Deng X, Liu Y, Xu Y, et al
    Naturally occurring antiviral drug resistance in HIV patients who are mono-infected or co-infected with HBV or HCV in China.
    J Med Virol. 2018 Mar 24. doi: 10.1002/jmv.25078.
    >> Share

  146. GAO L, Wang Y, Li Y, Dong Y, et al
    Genome-wide expression profiling analysis to identify key genes in the anti-HIV mechanism of CD4(+) and CD8(+) T cells.
    J Med Virol. 2018 Mar 6. doi: 10.1002/jmv.25071.
    >> Share

    February 2018
  147. ZHOU S, Ren L, Xia X, Miao Z, et al
    Hepatitis E virus infection in HIV-infected patients: a large cohort study in Yunnan province, China.
    J Med Virol. 2018 Feb 19. doi: 10.1002/jmv.25060.
    >> Share

  148. GRECO L, Renteria SCU, Guarneri D, Orlandi A, et al
    HEV and HAV seroprevalence in men that have sex with men (MSM): an update from Milan, Italy.
    J Med Virol. 2018 Feb 15. doi: 10.1002/jmv.25052.
    >> Share

  149. MANCINELLI S, Pirillo MF, Liotta G, Andreotti M, et al
    J Med Virol. 2018 Feb 10. doi: 10.1002/jmv.25049.
    >> Share

  150. RAO D, Venkataswamy MM, Vasanthapuram R, Satishchandra P, et al
    Alterations in natural killer and dendritic cell subsets in individuals with HIV-associated neurotuberculosis.
    J Med Virol. 2018 Feb 3. doi: 10.1002/jmv.25042.
    >> Share

    January 2018
  151. MARIO S, Carmine M, Stefania P, Margherita M, et al
    J Med Virol. 2018 Jan 9. doi: 10.1002/jmv.25022.
    >> Share

    December 2017
  152. VERGARA-ORTEGA DN, Sevilla-Reyes EE, Herrera-Ortiz A, Torres-Ibarra L, et al
    J Med Virol. 2017 Dec 13. doi: 10.1002/jmv.25003.
    >> Share

    November 2017
  153. SU S, Fairley CK, Sasadeusz J, He J, et al
    HBV, HCV, and HBV/HCV co-infection among HIV-positive patients in Hunan province, China: regimen selection, hepatotoxicity, and antiretroviral therapy outcome.
    J Med Virol. 2017 Nov 1. doi: 10.1002/jmv.24988.
    >> Share

    October 2017
  154. CARRASCO I, Arias A, Benitez-Gutierrez L, Lledo G, et al
    Baseline NS5A Resistance Associated Substitutions May Impair DAA Response in Real-World Hepatitis C Patients.
    J Med Virol. 2017 Oct 9. doi: 10.1002/jmv.24971.
    >> Share

  155. LIU Z, Fang Q, Zuo J, Chen Y, et al
    Global Epidemiology of Human Herpesvirus 8 in Men Who Have Sex with Men: A Systematic Review and Meta-analysis.
    J Med Virol. 2017 Oct 3. doi: 10.1002/jmv.24960.
    >> Share

  156. AMPONSAH-DACOSTA E, Selabe SG, Mphahlele MJ
    Evolution of the serologic and virologic course of occult HBV infection in therapy experienced HIV co-infected patients.
    J Med Virol. 2017 Oct 2. doi: 10.1002/jmv.24956.
    >> Share

    September 2017
  157. RAHMAN M, Hossain ME, Afrad MH, Hasan R, et al
    Hepatitis C Virus infections among clients attending an HIV testing and counseling center in Dhaka, Bangladesh.
    J Med Virol. 2017 Sep 28. doi: 10.1002/jmv.24955.
    >> Share

  158. UCCIFERRI C, Tamburro M, Falasca K, Sammarco ML, et al
    Prevalence of anal, oral, penile and urethral Human Papillomavirus in HIV infected and HIV uninfected men who have sex with men.
    J Med Virol. 2017 Sep 14. doi: 10.1002/jmv.24943.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016